The Factor V Leiden variant and risk of chronic thromboembolic pulmonary hypertension
Eur Respir J
.
2020 Oct 1;56(4):2000774.
doi: 10.1183/13993003.00774-2020.
Print 2020 Oct.
Authors
Mark W Dodson
1
,
Kelli Sumner
2
,
Jadyn Carlsen
2
,
Meghan M Cirulis
3
4
,
Emily L Wilson
3
,
Abhishek Gadre
5
,
Timothy M Fernandes
5
,
Lynette M Brown
3
4
,
D Hunter Best
2
6
7
,
C Gregory Elliott
3
4
Affiliations
1
Dept of Medicine, Intermountain Medical Center, Murray, UT, USA Mark.Dodson@imail.org.
2
ARUP Institute of Clinical and Experimental Pathology, ARUP Laboratories, Salt Lake City, UT, USA.
3
Dept of Medicine, Intermountain Medical Center, Murray, UT, USA.
4
Dept of Medicine, University of Utah, Salt Lake City, UT, USA.
5
Division of Pulmonary, Critical Care, and Sleep Medicine, University of California San Diego, La Jolla, CA, USA.
6
Dept of Pathology, University of Utah, Salt Lake City, UT, USA.
7
Dept of Pediatrics, University of Utah, Salt Lake City, UT, USA.
PMID:
32444403
DOI:
10.1183/13993003.00774-2020
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Factor V / genetics
Humans
Hypertension, Pulmonary* / epidemiology
Hypertension, Pulmonary* / genetics
Mutation
Risk Factors
Thrombophilia*
Substances
factor V Leiden
Factor V